{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:02:21Z","timestamp":1790179341020,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Nanjing Medical University-Qilu Clinical Research Fund Project","award":["2024KF0258"],"award-info":[{"award-number":["2024KF0258"]}]},{"name":"Suzhou Medical and Health Technology Innovation Project","award":["SYWD2025145; SYWD2024326"],"award-info":[{"award-number":["SYWD2025145; SYWD2024326"]}]},{"name":"Suzhou Strengthening Health through Science and Education Project","award":["MSXM2025033"],"award-info":[{"award-number":["MSXM2025033"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13326-2","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T11:47:00Z","timestamp":1776340020000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Epidemiology, antifungal susceptibility, risk factors, and mortality of adult candidemia at a tertiary hospital in Eastern China from 2020 to 2025"],"prefix":"10.1186","volume":"26","author":[{"given":"Yu-qiong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-nan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-jing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"issue":"5","key":"13326_CR1","doi-asserted-by":"publisher","first-page":"e268","DOI":"10.1016\/S1473-3099(24)00102-6","volume":"24","author":"KS Ikuta","year":"2024","unstructured":"Ikuta KS, Me\u0161trovi\u0107 T, Naghavi M. Global incidence and mortality of severe fungal disease. Lancet Infect Dis. 2024;24(5):e268.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"13326_CR2","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41572-024-00503-3","volume":"10","author":"C Lass-Fl\u00f6rl","year":"2024","unstructured":"Lass-Fl\u00f6rl C, Kanj SS, Govender NP, Thompson GR, Ostrosky- Zeichner L, Govrins MA. Invasive candidiasis. Nat Reviews Disease Primers. 2024;10(1):20.","journal-title":"Nat Reviews Disease Primers"},{"issue":"suppl3","key":"13326_CR3","doi-asserted-by":"publisher","first-page":"S445","DOI":"10.1093\/infdis\/jix131","volume":"216","author":"MC Arendrup","year":"2017","unstructured":"Arendrup MC, Patterson TF. Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment. J Infect Dis. 2017;216(suppl3):S445\u201351.","journal-title":"J Infect Dis"},{"issue":"7","key":"13326_CR4","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.cmi.2019.03.028","volume":"25","author":"KE Pristov","year":"2019","unstructured":"Pristov KE, Ghannoum MA. Resistance of Candida to azoles and echinocandins worldwide. Clin Microbiol Infect. 2019;25(7):792\u20138.","journal-title":"Clin Microbiol Infect"},{"key":"13326_CR5","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s11046-022-00640-x","volume":"187","author":"M Dom\u00e1n","year":"2022","unstructured":"Dom\u00e1n M, Makrai L, B\u00e1nyai K. Molecular Phylogenetic Analysis of Candida krusei. Mycopathologia. 2022;187:333\u201343.","journal-title":"Mycopathologia"},{"key":"13326_CR6","doi-asserted-by":"crossref","unstructured":"Beardsley J, Kim H, Dao A, Kidd S, Alastruey-Izquierdo A, Sorrell T, Tacconelli E, Chakrabarti A, Harrison T, Bongomin F et al. Candida glabrata (Nakaseomyces glabrata): A systematic review of clinical and microbiological data from 2011 to 2021 to inform the World Health Organization Fungal Priority Pathogens List. Med Mycol. 2024;62(6):myae041.","DOI":"10.1093\/mmy\/myae041"},{"key":"13326_CR7","doi-asserted-by":"crossref","unstructured":"Nucci M, Cassini A, Beardsley J. Pichia kudriavzevii (Candida krusei): A systematic review to inform the World Health Organisation priority list of fungal pathogens. Med Mycol. 2024;62(6):myad132 .","DOI":"10.1093\/mmy\/myad132"},{"issue":"Suppl 1","key":"13326_CR8","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1093\/ofid\/ofy358","volume":"6","author":"MA Pfaller","year":"2019","unstructured":"Pfaller MA, Diekema DJ, Turnidge JD, Castanheira M, Jones RN. Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997\u20132016. Open Forum Infect Dis. 2019;6(Suppl 1):S79\u201394.","journal-title":"Open Forum Infect Dis"},{"key":"13326_CR9","doi-asserted-by":"crossref","unstructured":"Xiao M, Sun Z, Kang M, Guo D, Liao K, Chen S, Kong F, Fan X, Cheng J-W, Hou X et al. Five-Year National Surveillance of Invasive Candidiasis: Species Distribution and Azole Susceptibility from the China Hospital Invasive Fungal Surveillance Net (CHIF-NET) Study. J Clin Microbiol. 2018;56(7):e00577\u201318.","DOI":"10.1128\/JCM.00577-18"},{"key":"13326_CR10","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1093\/jac\/dku460","volume":"70 3","author":"M Xiao","year":"2015","unstructured":"Xiao M, Fan X, Chen S, Wang H, Sun Z, Liao K, Chen S, Yan Y, Kang M, Hu Z-D, et al. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance. J Antimicrob Chemother. 2015;70 3:802\u201310.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"13326_CR11","doi-asserted-by":"publisher","first-page":"7240","DOI":"10.1038\/s41598-025-92100-x","volume":"15","author":"S Khan","year":"2025","unstructured":"Khan S, Cai L, Bilal H, Khan MN, Fang W, Zhang D, Yao F, Wang X, Wang Q, Hou B, et al. An 11-Year retrospective analysis of candidiasis epidemiology, risk factors, and antifungal susceptibility in a tertiary care hospital in China. Sci Rep. 2025;15(1):7240.","journal-title":"Sci Rep"},{"key":"13326_CR12","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.2147\/IDR.S471171","volume":"17","author":"L Chen","year":"2024","unstructured":"Chen L, Xie Z, Jian J. Epidemiology and Risk Factors of Candidemia a 8-Year Retrospective Study from a Teaching Hospital in China. Infect Drug Resist. 2024;17:3415\u201323.","journal-title":"Infect Drug Resist"},{"issue":"1","key":"13326_CR13","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1186\/s12879-025-11021-2","volume":"25","author":"X Chen","year":"2025","unstructured":"Chen X, Shen M, Feng Q, Yang G, Tian R, Yao S, Zha H. Epidemiological characteristics, antifungal susceptibility, and mortality factors of candidemia in adults at a tertiary teaching hospital in Zunyi, China (2016\u20132023). BMC Infect Dis. 2025;25(1):726.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"13326_CR14","doi-asserted-by":"publisher","first-page":"e280","DOI":"10.1016\/S1473-3099(24)00749-7","volume":"25","author":"OA Cornely","year":"2025","unstructured":"Cornely OA, Sprute R, Bassetti M, Chen SC, Groll AH, Kurzai O, Lass-Fl\u00f6rl C, Ostrosky-Zeichner L, Rautemaa-Richardson R, Revathi G, et al. Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM. Lancet Infect Dis. 2025;25(5):e280\u201393.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"13326_CR15","first-page":"PO22","volume":"11","author":"M Ahmed","year":"2023","unstructured":"Ahmed M, Upadhyay N, Ansari MI, Ali MA. Neonatal candidiasis: Clinical spectrum and epidemiology at a tertiary care centre, Bhopal, India. Int J Nurs Midwifery Research; Indian J Neonatal Med Res. 2023;11(1):PO22\u20135.","journal-title":"Int J Nurs Midwifery Research; Indian J Neonatal Med Res"},{"key":"13326_CR16","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1542\/peds.2008-2055","volume":"123","author":"C Blyth","year":"2009","unstructured":"Blyth C, Chen S, Slavin M, Serena C, Nguyen Q, Marriott D, Ellis D, Meyer W, Sorrell T. Not Just Little Adults: Candidemia Epidemiology, Molecular Characterization, and Antifungal Susceptibility in Neonatal and Pediatric Patients. Pediatrics. 2009;123:1360\u20138.","journal-title":"Pediatrics"},{"key":"13326_CR17","unstructured":"Clinical Microbiology Laboratory. Operating Procedures of Blood Culture. WS\/T 503\u20142017. Beijing: National Health Commission of the People's Republic of China; 2017."},{"key":"13326_CR18","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antifungal susceptibility testing of yeasts; CLSI document M27Ed3. 3rd ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2022."},{"key":"13326_CR19","unstructured":"National Health Commission of the People's Republic of China. Standards for antifungal susceptibility testing of yeasts\u2014Broth dilution method. WS\/T 421\u20142024. Beijing: National Health Commission of the People's Republic of China; 2024."},{"key":"13326_CR20","doi-asserted-by":"crossref","unstructured":"Zhang L, Wang H, Xiao M, Kudinha T, Mao L, Zhao H-R, Kong F, Xu Y. The widely used ATB FUNGUS 3 automated readings in China and its misleading high MICs of Candida spp. to azoles: challenges for developing countries\u2019 clinical microbiology labs. PLoS ONE 2014;9(12):e114004.","DOI":"10.1371\/journal.pone.0114004"},{"key":"13326_CR21","doi-asserted-by":"crossref","unstructured":"Arendrup M, Friberg N, Mare\u0219 M, Kahlmeter G, Meletiadis J, Guinea J, Arendrup M, Meletiadis J, Guinea J, Friberg N et al. How to: interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST). Clin Microbiol Infect. 2020;26(11):1464\u201372.","DOI":"10.1016\/j.cmi.2020.06.007"},{"key":"13326_CR22","doi-asserted-by":"publisher","first-page":"117863372110269","DOI":"10.1177\/11786337211026927","volume":"14","author":"FC Kotey","year":"2021","unstructured":"Kotey FC, Dayie NT, Tetteh-Uarcoo PB, Donkor ES. Candida Bloodstream Infections: Changes in Epidemiology and Increase in Drug Resistance. Infect Dis (Auckl). 2021;14:11786337211026927.","journal-title":"Infect Dis (Auckl)"},{"issue":"Suppl 2","key":"13326_CR23","doi-asserted-by":"publisher","first-page":"S139","DOI":"10.1093\/infdis\/jiz573","volume":"221","author":"M Xiao","year":"2020","unstructured":"Xiao M, Chen SC, Kong F, Xu XL, Yan L, Kong HS, Fan X, Hou X, Cheng JW, Zhou ML, et al. Distribution and Antifungal Susceptibility of Candida Species Causing Candidemia in China: An Update From the CHIF-NET Study. J Infect Dis. 2020;221(Suppl 2):S139\u201347.","journal-title":"J Infect Dis"},{"issue":"04","key":"13326_CR24","first-page":"234","volume":"16","author":"S Duan","year":"2021","unstructured":"Duan S, Xiao M, Huang J, Wang H, Zhang G, Zhang J, Kang W, Wang T, Xiao Y, Ni F, et al. Distribution characteristics of invasive yeast infections in China Hospital Invasive Fungal Surveillance Net (CHIF-NET) in 2012. Chin J Mycol. 2021;16(04):234\u201342.","journal-title":"Chin J Mycol"},{"issue":"3","key":"13326_CR25","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3390\/jof11030217","volume":"11","author":"SN Yu","year":"2025","unstructured":"Yu SN, Hong SI, Park JW, Jeon MH, Cho OH. Epidemiology and Clinical Features of Candida Bloodstream Infections: A 10-Year Retrospective Study in a Korean Teaching Hospital. J Fungi (Basel). 2025;11(3):217.","journal-title":"J Fungi (Basel)"},{"issue":"6","key":"13326_CR26","doi-asserted-by":"publisher","first-page":"465","DOI":"10.3390\/jof11060465","volume":"11","author":"S Cugnata","year":"2025","unstructured":"Cugnata S, Sacheli R, Layios N, Hayette MP. Species Distribution and Antifungal Susceptibility Patterns of Invasive Candidiasis in a Belgian Tertiary Center: A 7-Year Retrospective Analysis. J Fungi (Basel). 2025;11(6):465.","journal-title":"J Fungi (Basel)"},{"issue":"1","key":"13326_CR27","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s13054-019-2497-3","volume":"23","author":"M Bassetti","year":"2019","unstructured":"Bassetti M, Giacobbe DR, Vena A, Trucchi C, Ansaldi F, Antonelli M, Adamkova V, Alicino C, Almyroudi MP, Atchade E, et al. Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project. Crit Care. 2019;23(1):219.","journal-title":"Crit Care"},{"key":"13326_CR28","doi-asserted-by":"crossref","unstructured":"Wang Y, Fan X, Wang H, Kudinha T, Mei Y-N, Ni F, Pan Y-H, Gao L, Xu H, Kong H et al. Continual decline in azole susceptibility rates in candida tropicalis over a 9-year period in China. Front Microbiol. 2021;12:702839.","DOI":"10.3389\/fmicb.2021.702839"},{"key":"13326_CR29","doi-asserted-by":"crossref","unstructured":"Keighley C, Kim H, Kidd S, Chen SCa, Alastruey A, Dao A, Bongomin F, Chiller T, Wahyuningsih R, Forastiero A et al. Candida tropicalis\u2014a systematic review to inform the World Health Organization of a fungal priority pathogens list. Med Mycol. 2024;62(6):myae040.","DOI":"10.1093\/mmy\/myae040"},{"key":"13326_CR30","doi-asserted-by":"crossref","unstructured":"Hu T, Wang S, Bing J, Zheng Q, Du H, Li C, Guan Z, Bai F-Y, Nobile C, Chu H et al. Hotspot mutations and genomic expansion of ERG11 are major mechanisms of azole resistance in environmental and human commensal isolates of Candida tropicalis. Int J Antimicrob Agents. 2023;62(6):107010.","DOI":"10.1016\/j.ijantimicag.2023.107010"},{"key":"13326_CR31","doi-asserted-by":"crossref","unstructured":"Castanheira M, Deshpande L, Davis A, Carvalhaes C, Pfaller M. Azole resistance in Candida glabrata clinical isolates from global surveillance is associated with efflux overexpression. J Glob Antimicrob Resist. 2022;29:371\u20137.","DOI":"10.1016\/j.jgar.2022.05.004"},{"key":"13326_CR32","doi-asserted-by":"crossref","unstructured":"Chesdachai S, Yetmar Z, Ranganath N, Everson J, Wengenack N, Saleh OA. Antifungal susceptibility pattern of Candida glabrata from a referral center and reference laboratory: 2012\u20132022. J Fungi (Basel). 2023;9(8):821.","DOI":"10.3390\/jof9080821"},{"key":"13326_CR33","doi-asserted-by":"crossref","unstructured":"Dawoud A, Saied S, Torayah M, Ramadan A, Elaskary S. Antifungal susceptibility and virulence determinants profile of Candida species isolated from patients with candidemia. Sci Rep 2024;14(1):11597.","DOI":"10.1038\/s41598-024-61813-w"},{"key":"13326_CR34","doi-asserted-by":"crossref","unstructured":"Czajka K, Venkataraman K, Brabant-Kirwan D, Santi S, Verschoor C, Appanna V, Singh R, Saunders D, Tharmalingam S. Molecular mechanisms associated with antifungal resistance in pathogenic Candida species. Cells. 2023;12(22):2655.","DOI":"10.3390\/cells12222655"},{"key":"13326_CR35","doi-asserted-by":"crossref","unstructured":"Yamin D, Akanmu MH, Mutair AA, Alhumaid S, Rabaan A, Hajissa K. Global prevalence of antifungal-resistant Candida parapsilosis: a systematic review and meta-analysis. Trop Med Infect Disease. 2022;7(8):188.","DOI":"10.3390\/tropicalmed7080188"},{"issue":"4","key":"13326_CR36","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/civ933","volume":"62","author":"PG Pappas","year":"2016","unstructured":"Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, Reboli AC, Schuster MG, Vazquez JA, Walsh TJ, et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62(4):e1\u201350.","journal-title":"Clin Infect Dis"},{"key":"13326_CR37","doi-asserted-by":"crossref","unstructured":"Cabrera-Guerrero JP, Garc\u00eda-Salazar E, Silva GH, Herrera AC, Mart\u00ednez-Herrera E, Pinto-Almaz\u00e1n R, Fr\u00edas-De-Le\u00f3n M, Castro-Fuentes C. Candidemia: An Update on epidemiology, risk factors, diagnosis, susceptibility, and treatment. Pathogens. 2025;14(8):806.","DOI":"10.3390\/pathogens14080806"},{"issue":"suppl1","key":"13326_CR38","doi-asserted-by":"publisher","first-page":"i14","DOI":"10.1093\/jac\/dkx445","volume":"73","author":"M Bassetti","year":"2018","unstructured":"Bassetti M, Righi E, Montravers P, Cornely OA. What has changed in the treatment of invasive candidiasis? A look at the past 10 years and ahead. J Antimicrob Chemother. 2018;73(suppl_1):i14\u201325.","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"13326_CR39","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s00134-019-05599-w","volume":"45","author":"I Martin-Loeches","year":"2019","unstructured":"Martin-Loeches I, Antonelli M, Cuenca-Estrella M, Dimopoulos G, Einav S, De Waele JJ, Garnacho-Montero J, Kanj SS, Machado FR, Montravers P, et al. ESICM\/ESCMID task force on practical management of invasive candidiasis in critically ill patients. Intensive Care Med. 2019;45(6):789\u2013805.","journal-title":"Intensive Care Med"},{"issue":"10","key":"13326_CR40","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.cmi.2019.04.024","volume":"25","author":"P Koehler","year":"2019","unstructured":"Koehler P, Stecher M, Cornely OA, Koehler D, Vehreschild M, Bohlius J, Wisplinghoff H, Vehreschild JJ. Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis. Clin Microbiol Infect. 2019;25(10):1200\u201312.","journal-title":"Clin Microbiol Infect"},{"key":"13326_CR41","doi-asserted-by":"publisher","first-page":"103227","DOI":"10.1016\/j.iccn.2022.103227","volume":"70","author":"S Blot","year":"2022","unstructured":"Blot S, Rupp\u00e9 E, Harbarth S, Asehnoune K, Poulakou G, Luyt CE, Rello J, Klompas M, Depuydt P, Eckmann C, et al. Healthcare-associated infections in adult intensive care unit patients: Changes in epidemiology, diagnosis, prevention and contributions of new technologies. Intensive Crit Care Nurs. 2022;70:103227.","journal-title":"Intensive Crit Care Nurs"},{"issue":"1","key":"13326_CR42","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13054-020-2766-1","volume":"24","author":"J Poissy","year":"2020","unstructured":"Poissy J, Damonti L, Bignon A, Khanna N, Von Kietzell M, Boggian K, Neofytos D, Vuotto F, Coiteux V, Artru F, et al. Risk factors for candidemia: a prospective matched case-control study. Crit Care. 2020;24(1):109.","journal-title":"Crit Care"},{"key":"13326_CR43","doi-asserted-by":"crossref","unstructured":"Salmanton-Garc\u00eda J, Cornely O, Stemler J, Bara\u0107 A, Steinmann J, Siv\u00e1kov\u00e1 A, Akal\u0131n E, Arikan-Akdagli S, Loughlin L, Toscano C et al. Attributable mortality of candidemia - Results from the ECMM Candida III multinational European Observational Cohort Study. J Infect 2024;89(3):106229.","DOI":"10.1016\/j.jinf.2024.106229"},{"issue":"1","key":"13326_CR44","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1093\/jac\/dks347","volume":"68","author":"J Garnacho-Montero","year":"2013","unstructured":"Garnacho-Montero J, D\u00edaz-Mart\u00edn A, Garc\u00eda-Cabrera E, Ruiz P\u00e9rez de Pipa\u00f3n M, Hern\u00e1ndez-Caballero C, Lepe-Jim\u00e9nez JA. Impact on hospital mortality of catheter removal and adequate antifungal therapy in Candida spp. bloodstream infections. J Antimicrob Chemother. 2013;68(1):206\u201313.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"13326_CR45","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/myc.13211","volume":"64","author":"CL Keighley","year":"2021","unstructured":"Keighley CL, Pope A, Marriott DJE, Chapman B, Bak N, Daveson K, Hajkowicz K, Halliday C, Kennedy K, Kidd S, et al. Risk factors for candidaemia: A prospective multi-centre case-control study. Mycoses. 2021;64(3):257\u201363.","journal-title":"Mycoses"},{"issue":"7","key":"13326_CR46","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1161\/CIRCULATIONAHA.106.678359","volume":"116","author":"MW Merx","year":"2007","unstructured":"Merx MW, Weber C. Sepsis and the Heart. Circulation. 2007;116(7):793\u2013802.","journal-title":"Circulation"},{"key":"13326_CR47","doi-asserted-by":"crossref","unstructured":"Sambo CT, De Almeida B, Fialkovitz G, Cocio T, Da Silva A, Siqueira L, Silva ICO, Rossi F, Guimar\u00e3es T, Siciliano R et al. Nine-year surveillance of Candida parapsilosis Candidemia in a Cardiothoracic ICU: insights into mortality and resistance. J Fungi. 2025;11(10):692.","DOI":"10.3390\/jof11100692"},{"key":"13326_CR49","doi-asserted-by":"crossref","unstructured":"Zhang W, Song X, Wu H-T, Zheng R. Epidemiology, species distribution, and predictive factors for mortality of candidemia in adult surgical patients. BMC Infect Dis. 2020;20(1):506.","DOI":"10.1186\/s12879-020-05238-6"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13326-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13326-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13326-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T23:23:34Z","timestamp":1779837814000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13326-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13326"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13326-2","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]},"assertion":[{"value":"12 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Ethics Committee of The Affiliated Suzhou Hospital of Nanjing Medical University (Approval No. K-2024-144-K01). This is a retrospective study. The need for informed consent was waived by the Ethics Committee of The Affiliated Suzhou Hospital of Nanjing Medical University. This study was conducted in full accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1037"}}